Ginkgo Bioworks Holdings Stock Performance
| DNA Stock | USD 9.22 0.47 4.85% |
On a scale of 0 to 100, Ginkgo Bioworks holds a performance score of 3. The company retains a Market Volatility (i.e., Beta) of 3.26, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ginkgo Bioworks will likely underperform. Please check Ginkgo Bioworks' total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Ginkgo Bioworks' current trending patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.85) | Five Day Return 0.66 | Year To Date Return 5.98 | Ten Year Return (97.72) | All Time Return (97.72) |
Last Split Factor 1:40 | Last Split Date 2024-08-20 |
1 | Disposition of 1061 shares by Mark Dmytruk of Ginkgo Bioworks subject to Rule 16b-3 | 11/28/2025 |
2 | Disposition of 1244 shares by Mark Dmytruk of Ginkgo Bioworks at 7.283 subject to Rule 16b-3 | 12/01/2025 |
3 | Disposition of 312 shares by Coen Steven P. of Ginkgo Bioworks subject to Rule 16b-3 | 12/12/2025 |
4 | Disposition of 736 shares by Coen Steven P. of Ginkgo Bioworks at 8.886 subject to Rule 16b-3 | 12/15/2025 |
5 | MySize Explores Unlocking the DNA of Fashion Through Privacy-First Data Intelligence | 01/13/2026 |
6 | Disposition of 587 shares by Coen Steven P. of Ginkgo Bioworks subject to Rule 16b-3 | 01/16/2026 |
7 | High-tech DNA could ID cold-case Asian Doe Gilgo Beach victim DA | 01/21/2026 |
8 | Theanti-aging supplement Kim Kardashian andBryan Johnson have in common its more effective than NAD | 01/29/2026 |
9 | Ginkgo Bioworks Autonomous Laboratory Driven by OpenAIs GPT-5 Achieves 40 percent Improvement Over State-of-the-Art Scientific Benchmark | 02/05/2026 |
10 | Decomposed leg confirmed as missing California teens 51-year-old man charged with murder | 02/17/2026 |
11 | Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products | 02/18/2026 |
12 | Brutal decades-old murder of California girl solved thanks to cigarette DNA Coldest case ever | 02/20/2026 |
| Begin Period Cash Flow | 989.6 M | |
| Total Cashflows From Investing Activities | -62.2 M |
Ginkgo Bioworks Relative Risk vs. Return Landscape
If you would invest 871.00 in Ginkgo Bioworks Holdings on November 25, 2025 and sell it today you would earn a total of 51.00 from holding Ginkgo Bioworks Holdings or generate 5.86% return on investment over 90 days. Ginkgo Bioworks Holdings is generating 0.2142% of daily returns assuming volatility of 5.0159% on return distribution over 90 days investment horizon. In other words, 45% of stocks are less volatile than Ginkgo, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Ginkgo Bioworks Target Price Odds to finish over Current Price
The tendency of Ginkgo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.22 | 90 days | 9.22 | about 37.33 |
Based on a normal probability distribution, the odds of Ginkgo Bioworks to move above the current price in 90 days from now is about 37.33 (This Ginkgo Bioworks Holdings probability density function shows the probability of Ginkgo Stock to fall within a particular range of prices over 90 days) .
Ginkgo Bioworks Price Density |
| Price |
Predictive Modules for Ginkgo Bioworks
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ginkgo Bioworks Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ginkgo Bioworks Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ginkgo Bioworks is not an exception. The market had few large corrections towards the Ginkgo Bioworks' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ginkgo Bioworks Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ginkgo Bioworks within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 3.26 | |
σ | Overall volatility | 0.65 | |
Ir | Information ratio | 0.05 |
Ginkgo Bioworks Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ginkgo Bioworks for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ginkgo Bioworks Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ginkgo Bioworks had very high historical volatility over the last 90 days | |
| Ginkgo Bioworks has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 227.04 M. Reported Net Loss for the year was (547.03 M) with profit before taxes, overhead, and interest of 131.31 M. | |
| Ginkgo Bioworks Holdings has about 561.57 M in cash with (319.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures | |
| Roughly 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from nypost.com: Brutal decades-old murder of California girl solved thanks to cigarette DNA Coldest case ever |
Ginkgo Bioworks Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ginkgo Stock often depends not only on the future outlook of the current and potential Ginkgo Bioworks' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ginkgo Bioworks' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.9 M | |
| Cash And Short Term Investments | 561.6 M |
Ginkgo Bioworks Fundamentals Growth
Ginkgo Stock prices reflect investors' perceptions of the future prospects and financial health of Ginkgo Bioworks, and Ginkgo Bioworks fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ginkgo Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (1.88) % | ||||
| Operating Margin | (2.27) % | ||||
| Current Valuation | 519.65 M | ||||
| Shares Outstanding | 48.52 M | ||||
| Price To Earning | 25.51 X | ||||
| Price To Book | 1.00 X | ||||
| Price To Sales | 3.09 X | ||||
| Revenue | 227.04 M | ||||
| Gross Profit | 131.31 M | ||||
| EBITDA | (484.39 M) | ||||
| Net Income | (547.03 M) | ||||
| Cash And Equivalents | 561.57 M | ||||
| Cash Per Share | 0.84 X | ||||
| Total Debt | 467.73 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 11.84 X | ||||
| Book Value Per Share | 9.85 X | ||||
| Cash Flow From Operations | (319.58 M) | ||||
| Earnings Per Share | (6.18) X | ||||
| Market Capitalization | 558.64 M | ||||
| Total Asset | 1.38 B | ||||
| Retained Earnings | (5.84 B) | ||||
| Working Capital | 495.48 M | ||||
| Current Asset | 10.07 B | ||||
| Current Liabilities | 3.1 B | ||||
About Ginkgo Bioworks Performance
By analyzing Ginkgo Bioworks' fundamental ratios, stakeholders can gain valuable insights into Ginkgo Bioworks' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ginkgo Bioworks has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ginkgo Bioworks has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.36 | 0.34 | |
| Return On Tangible Assets | (0.48) | (0.51) | |
| Return On Capital Employed | (0.51) | (0.53) | |
| Return On Assets | (0.46) | (0.48) | |
| Return On Equity | (0.88) | (0.92) |
Things to note about Ginkgo Bioworks Holdings performance evaluation
Checking the ongoing alerts about Ginkgo Bioworks for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ginkgo Bioworks Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ginkgo Bioworks had very high historical volatility over the last 90 days | |
| Ginkgo Bioworks has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 227.04 M. Reported Net Loss for the year was (547.03 M) with profit before taxes, overhead, and interest of 131.31 M. | |
| Ginkgo Bioworks Holdings has about 561.57 M in cash with (319.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures | |
| Roughly 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from nypost.com: Brutal decades-old murder of California girl solved thanks to cigarette DNA Coldest case ever |
- Analyzing Ginkgo Bioworks' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ginkgo Bioworks' stock is overvalued or undervalued compared to its peers.
- Examining Ginkgo Bioworks' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ginkgo Bioworks' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ginkgo Bioworks' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ginkgo Bioworks' stock. These opinions can provide insight into Ginkgo Bioworks' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |